For investors
HDIM is a data-sovereignty-native healthcare interoperability platform. It lands on feed quality, expands into care-gap and quality workflows, and surfaces operator-safe intelligence — without moving PHI out of the customer boundary.
The investor cut of the HDIM flagship explainer.
One entry point every healthcare organization needs — feed quality — expanding into coordinated workflows and cross-customer intelligence.
1 · Land
The entry wedge. An on-premises data-quality trust authority that scores inbound and outbound feeds across five dimensions and gates feed/identity readiness. Feed quality is a need every data-sharing healthcare organization has.
2 · Expand
The customer-boundary runtime for care-gap detection and HEDIS quality workflows, powered by DQM-validated signals and gated by identity and consent controls.
3 · Operate
The cloud operator-evidence tier. Ingests operator-safe aggregates so operators triage cross-customer evidence without seeing patient-level PHI — deny-list enforced, de-identified, small-cell floor (k ≥ 11).
We separate what is built and verifiable today from what is still modeled. We would rather you trust the package than be surprised in diligence.
Standards-native architecture
FHIR R4 service patterns, event-driven/event-sourced domains, shared multi-tenant controls — code-validated, not pitch-only.
Architecture →Engineering evidence
Validation dashboard: test suites, entity-migration validation, contract testing, rollback coverage.
Validation →API contracts
OpenAPI 3.0 service contracts across the core services — interactive reference.
API reference →Live, synthetic demos
DQM, the Data Motion Platform clinical portal, and the Atlas Nexus operator surface — synthetic data only.
Live demos →Financial ROI / cost savings
Our ROI calculator produces an illustrative model from your inputs and published assumptions. Hard, audited outcome numbers are gated behind paid pilots — by design, this package carries no claimed financial metric.
ROI model (illustrative) →Market size & commercial traction
Pipeline, pricing, and market-size framing are handled in NDA materials with sourced assumptions, not asserted as fact on this page.
Security attestations
HIPAA-aligned controls and SOC 2 readiness are in place; external attestation/pentest is on the roadmap, not claimed as complete.
The investor brief and the gated evidence room hold the technical diligence package. We'll tailor a walkthrough to your thesis.